The aim of the study was to find out the quality of life in patients with type-2 diabetes mellitus. Material and Method: A descriptive survey design was conducted among 100 Type-2 diabetic patients attending Rajah Muthiah Medical College and Hospital, Chidambaram Tamilnadu for a period of one year. Information regarding socio-demographic characteristics like age, gender, occupation, personal history, education, etc. was collected in pretested proforma by interview method. Assessment of QOL of life was done using the Quality Of Life Instrument for Indian diabetic [QOLID] questionnaire. The data entry and statistical analysis were done using Microsoft Excel and SPS22 version. Data collected from the patient in QOL were analyzed using descriptive statistics. Results: Among 100 study participants majority, 45% belonged to age group of 51-60years, 63% were female, 49% belonged to lower socioeconomic class according to BG Prasad classification, 82 percent were married,49%were overweight, 51% were having family history of diabetes, 50%were having visual impairment, 92% were on oral hypoglycemic medication the mean total of QOLID questioner score in physical health was 19.0, physical endurance 18.33,general health 7.09, treatment satisfaction 12.4, symptom bothered 10.7, financial worries 13.44, mental health 14.5 and diet satisfaction 8.44. However, the study result shows that the physical component was more affected in diabetic patients. Conclusion: This study observed Physical component was affected in diabetic persons. The study concluded that patients with Type-2 diabetes mellitus had relatively impact in health-related quality of life (PH, PE & GH) domains and unsubstantial in diabetes-specific quality of life (SB, TS FW, MH&DS) domains.
Aim and Objective: To evaluate the relationship between serum ferritin and metabolic syndrome. Methods: The patients attending Rajah Muthiah Medical College & Hospital inpatient department are being screened for metabolic syndrome on the basis of NCEP: ATP III 2001 and harmonizing definition criteria. Based on the inclusion and exclusion criteria the patients are being enrolled into this study. Informed consent will be obtained from the patients before including them in the study. Materials and Methods: Design : Hospital based observational study. Place of Study : Department of General Medicine. Study Population : Cases attending the RMMCH inpatient department during the study period. Sample Size : 70. Study Period : November 2019 to April 2021.
Results:In this study, we observed type 2 diabetes mellitus in 63 (90%) patients, systemic hypertension in 57 (81%) patients, elevated triglycerides in 28 (40%) patients, decreased HDL cholesterol in 13 (19%) patients and central adiposity was seen in all of the patients. In this study we were able to observe that serum ferritin which was elevated above average levels can be used as a marker for metabolic syndrome since ferritin is an acute phase reactant and metabolic syndrome is a pro inflammatory condition.
Conclusion:There is a positive association between elevated serum ferritin (above average levels) and metabolic syndrome indicating it is a pro inflammatory condition.
To estimate the level of fibrinogen in patients with type 2 diabetes mellitus. Methods: We conducted a hospital based study of 100 random patients, divided into 4 groups, 25 in each group and compared serum fibrinogen between the group during the study period from November 2019 to April 2021. The patients will be sub classified into four groups: Patients with type 2 diabetes mellitus without complications (Group -A).
Patients with type 2 diabetes mellitus with microvascular complications (Group -B).
Patients with type 2 diabetes mellitus with macrovascular complications (Group -C).
Patients with type2 diabetes mellitus with both microvascular and macrovascular complications (Group -D). Results: The difference between serum fibrinogen levels among 4 groups were statistically significant (p< 0.001) Conclusion: Fibrinogen could be potential marker for prediction and prevention of microvascular and macrovascular complication.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.